Cpg Oligonucleotide Prodrugs, Compositions Thereof And Associated Therapeutic Methods
Cpg Oligonucleotide Prodrugs, Compositions Thereof And Associated Therapeutic Methods
Description
Abstract:
-
-
- The present invention provides a CpG oligonucleotide prodrug that includes a thermolabile substituent on at least one nucleotide thereof. The present invention also provides compositions that include a carrier and a therapeutically effective amount of at least one CpG oligonucleotide prodrug. The present invention further provides therapeutic methods of using such thermolabile CpG oligonucleotide prodrugs and compositions thereof. The present invention further provides a method of inhibiting tetrad formation in a CpG oligonucleotide by functionalizing the CpG oligonucleotide with one or more thermolabile substituents.
-
Issue/Publication date:
| 09/07/2017 |
There are no reviews yet.